Dose-Escalation Study of TH-302 in Combination With Doxorubicin to Treat Patients With Advanced Soft Tissue Sarcoma
Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether TH-302 in combination with Doxorubicin is
safe and effective in the treatment of Advanced Soft Tissue Sarcoma.